Verano HoldingsVRNOD +0.19%65 Current Ratio is 3.32 as of Mar. 2026, which is 249% above its 10-year median of 0.95. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 998 Drug Manufacturers companies, Verano Holdings ranks better than 71.14% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Verano Holdings's current ratio for the quarter that ended in Mar. 2026 was 3.32.
Verano Holdings has a current ratio of 3.32. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Verano Holdings's Current Ratio or its related term are showing as below:
VRNOD'
s Current Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.95 Max: 3.32
Current: 3.32
During the past 7 years, Verano Holdings's highest Current Ratio was 3.32. The lowest was 0.01. And the median was 0.95.
VRNOD's Current Ratio is ranked better than 71.14% of 998
companies
in the Drug Manufacturers industry
Industry Median: 2
vs VRNOD: 3.32
Verano Holdings (OTCPK:VRNOD) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Verano Holdings Current Ratio Related Terms
Verano Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for Verano Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Verano Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a Current Ratio of 3.32 as of Mar. 2026. This is 249% above median its historical median of 0.95. Over the past decade, Verano Holdings' Current Ratio has ranged from 0.01 to 3.32. According to the industry distribution chart, Verano Holdings ranks #288 out of 998 companies in the Drug Manufacturers industry, placing it in the top 28.9%.
Is Verano Holdings' Current Ratio too high?
Verano Holdings' current Current Ratio of 3.32 is 249% above median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 3.32. The Drug Manufacturers industry median Current Ratio is 2.00. Verano Holdings' value of 3.32 is 66% above this industry median. Based on the distribution chart, Verano Holdings ranks #288 out of 998 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #288 out of 998 companies for Current Ratio. This puts Verano Holdings in the upper half of its industry. The industry median Current Ratio is 2.00. Verano Holdings' value of 3.32 is 66% above this benchmark. Historically, Verano Holdings' own Current Ratio has ranged from 0.01 to 3.32 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 2.00, Verano Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current Current Ratio of 3.32 is 66% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current Current Ratio is 3.32, which is 249% above median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current Current Ratio is 3.32, which is 249% above median its 10-year median of 0.95 and 66% above the Drug Manufacturers industry median of 2.00. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current Current Ratio is 3.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
Current Ratio: 3.32 (249% above median its 10-year median of 0.95)
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
Industry Position: 66% above the Drug Manufacturers median (#288 of 998)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
